27.01.2020, 1248 Zeichen

Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
personal data:
responsible party:
name: Brigitte EDERER (natural person)
reason:
reason: responsible party is a person with managerial responsibilities function: Member of an administrative or supervisory board
issuer information:
name: Marinomed Biotech AG Legal Entity Identifier (LEI): 529900GN3B1EN80XF405
information about deal:
ISIN: ATMARINOMED6 description of the financial instrument: Share type: acquisition date: 23.01.2020; UTC+01:00 market: Vienna Stock Exchange AG, XWBO currency: Euro
price volume EUR 97 150 shares
total volume: 150 shares total price: EUR 14,550 average price: EUR 97
end of announcement euro adhoc
issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: ATMARINOMED6, AT0000A1WD52 indexes: stockmarkets: Wien language: English
Digital press kit: http://www.ots.at/pressemappe/31479/aom

Christian Drastil: Wiener Börse Plausch

SportWoche Podcast #118: Wie funktioniert der Tanzsport und welche Disziplinen gibt es, Gerhard Massenbauer?

Marinomed Biotech

Bildnachweis

1. Marinomed - Starke Partner für beschleunigtes Wachstum   >> Öffnen auf photaq.com

Aktien auf dem Radar:Warimpex, Bawag, FACC, Austriacard Holdings AG, Lenzing, Polytec Group, Telekom Austria, Österreichische Post, SBO, CA Immo, Wienerberger, Zumtobel, DO&CO, Palfinger, ams-Osram, AT&S, Cleen Energy, Wolftank-Adisa, Oberbank AG Stamm, Wolford, Agrana, Amag, Erste Group, EVN, Flughafen Wien, Immofinanz, S Immo, Uniqa, VIG, Sartorius, Travelers Companies.

---

Mehr aktuelle OTS-Meldungen HIER